Evidence map›Paper›PMID 38793398›Full record

ArticleMaterials (Basel, Switzerland)2024

Investigating Internalization of Reporter-Protein-Functionalized Polyhedrin Particles by Brain Immune Cells.

Krishma A K Parwana, Priyapreet Kaur Gill, Runyararo Njanike, Humphrey H P Yiu, Chris F Adams, Divya Maitreyi Chari, Stuart Iain Jenkins

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Krishma A K ParwanaSchool of Life Sciences, Keele University, Keele ST5 5BG, UK.ORCID 0009-0001-7423-354X
Priyapreet Kaur GillSchool of Medicine, Keele University, Keele ST5 5BG, UK.
Runyararo NjanikeSchool of Medicine, Keele University, Keele ST5 5BG, UK.
Humphrey H P YiuSchool of Engineering & Physical Sciences, University of Edinburgh, Edinburgh EH14 4AS, UK.
Chris F AdamsSchool of Life Sciences, Keele University, Keele ST5 5BG, UK.
Divya Maitreyi ChariSchool of Medicine, Keele University, Keele ST5 5BG, UK.
Stuart Iain JenkinsSchool of Medicine, Keele University, Keele ST5 5BG, UK.ORCID 0000-0002-9857-957X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achieving sustained drug delivery to the central nervous system (CNS) is a major challenge for neurological injury and disease, and various delivery vehicles are being developed to achieve this. Self-assembling polyhedrin crystals (POlyhedrin Delivery System; PODS) are being exploited for the delivery of therapeutic protein cargo, with demonstrated efficacy in vivo. However, to establish the utility of PODS for neural applications, their handling by neural immune cells (microglia) must be documented, as these cells process and degrade many biomaterials, often preventing therapeutic efficacy. Here, primary mouse cortical microglia were cultured with a GFP-functionalized PODS for 24 h. Cell counts, cell morphology and Iba1 expression were all unaltered in treated cultures, indicating a lack of acute toxicity or microglial activation. Microglia exhibited internalisation of the PODS, with both cytosolic and perinuclear localisation. No evidence of adverse effects on cellular morphology was observed. Overall, 20-40% of microglia exhibited uptake of the PODS, but extracellular/non-internalised PODS were routinely present after 24 h, suggesting that extracellular drug delivery may persist for at least 24 h.

Indexed as

crystalsdrug deliverydrug depotGFPmicrogliamicroparticlesnanoparticlesneuralnucleuspolyhedra

Identifiers

PMID38793398
PMCPMC11122724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.